Amprius Technologies (NYSE:AMPX) Trading Down 6.3% - Here's Why

Key Points

• Amprius shares dropped 6.3% on Friday to about $16.07, with roughly 6.8 million shares traded (about 24% below its average daily volume) after closing at $17.16 the prior day.
• Analyst sentiment is broadly positive — a consensus Moderate Buy with eight Buys and one Sell — and the average price target is $19.75, with several firms (Roth MKM, Needham) raising targets to $20.00.
• The company beat quarterly estimates (EPS -$0.01 vs. -$0.04 and revenue $25.23M vs. $22.91M) but remains unprofitable (net margin -60.3%; FY2026 guidance -$0.06 EPS), and insiders sold about 3.15 million shares worth ~$41.9M in the last quarter.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report)'s stock price dropped 6.3% during trading on Friday . The stock traded as low as $15.90 and last traded at $16.0740. Approximately 6,798,691 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 8,954,087 shares. The stock had previously closed at $17.16.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AMPX. Roth Mkm reaffirmed a "buy" rating and issued a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a report on Friday, March 6th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Oppenheimer reissued an "outperform" rating and set a $17.00 price objective on shares of Amprius Technologies in a research note on Tuesday, December 23rd. William Blair restated an "outperform" rating on shares of Amprius Technologies in a research note on Friday, March 6th. Finally, Needham & Company LLC restated a "buy" rating and issued a $20.00 target price on shares of Amprius Technologies in a research note on Tuesday, March 10th. Eight research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $19.75.

Amprius Technologies Stock Performance

The stock's 50 day simple moving average is $13.47 and its 200 day simple moving average is $11.77. The firm has a market cap of $2.20 billion, a PE ratio of -47.28 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. The firm had revenue of $25.23 million for the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. As a group, analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, Director Steven Chu sold 166,632 shares of the business's stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $17.92, for a total value of $2,986,045.44. Following the completion of the sale, the director directly owned 127,339 shares of the company's stock, valued at $2,281,914.88. The trade was a 56.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CTO Constantin Ionel Stefan sold 492,827 shares of the company's stock in a transaction dated Thursday, January 22nd. The shares were sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the sale, the chief technology officer owned 748,696 shares of the company's stock, valued at approximately $9,014,299.84. The trade was a 39.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,147,226 shares of company stock worth $41,879,047 in the last quarter. 12.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Amprius Technologies

Several institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE increased its stake in Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock worth $36,000 after purchasing an additional 3,055 shares during the period. Ameritas Investment Partners Inc. boosted its stake in shares of Amprius Technologies by 2,043.2% during the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company's stock valued at $40,000 after purchasing an additional 9,072 shares during the period. Quarry LP bought a new position in shares of Amprius Technologies in the third quarter worth approximately $42,000. Rhumbline Advisers increased its stake in shares of Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company's stock worth $42,000 after buying an additional 5,951 shares during the period. Finally, Legal & General Group Plc increased its position in shares of Amprius Technologies by 1,385.4% in the second quarter. Legal & General Group Plc now owns 10,383 shares of the company's stock valued at $44,000 after acquiring an additional 9,684 shares during the period. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

Amprius Technologies Company Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.